Evidence map›Paper›PMID 33283578›Full record

Observational studyJournal of the American Heart Association2020

Independent Impact of Peripheral Artery Disease on Percutaneous Coronary Intervention.

Leor Perl, Tamir Bental, Hana Vaknin-Assa, Abid Assali, Pablo Codner, Yeela Talmor-Barkan, Gabriel Greenberg, Abed Samara, Guy Witberg, Katia Orvin and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Leor PerlDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Tamir BentalDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Hana Vaknin-AssaDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Abid AssaliDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Pablo CodnerDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Yeela Talmor-BarkanDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Gabriel GreenbergDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Abed SamaraDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Guy WitbergDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Katia OrvinDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Ran KornowskiDepartment of Cardiology Rabin Medical Center Petach-Tikva Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Peripheral artery disease (PAD) is a known risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention. However, in some studies PAD is not an independent risk factor. We sought to examine the independent impact of PAD on a large prospective percutaneous coronary intervention registry. Methods and Results From our single-center prospective percutaneous coronary intervention registry, we have retrospectively analyzed 25 690 patients (years 2004-2018). We examined the influence of PAD on short- and long-term outcomes using both regression and propensity-matched analyses. Patients with documented PAD (n=1610, 6.3% of total) were older (66.7±10.8 versus 65.4±12.1,

Indexed as

AgedCardiovascular DiseasesCause of DeathDiabetes MellitusFemaleHumansHypertensionMaleMiddle AgedPercutaneous Coronary InterventionPeripheral Arterial DiseasePlatelet Aggregation InhibitorsPrasugrel HydrochlorideProspective StudiesPurinergic P2Y Receptor AntagonistsRegistriesPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelorpatient outcomespercutaneous coronary interventionperipheral artery disease

Identifiers

PMID33283578
PMCPMC7955381
OpenAlexW3111488223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.